News

Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 ...
Scottish Land & Estates reveals a bold vision to reshape rural policy, land use and environment for a thriving, future-proofed countryside.
Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the expansion of its Scientific Advisory Board to ...
The Interleukin-2 (IL-2) market is witnessing rapid growth due to advancements in cancer immunotherapy and autoimmune disease management. IL-2, a vital cytokine, promotes T-cell growth, with therapies ...
With a medical sciences degree, you’ll enhance your credentials for entry into medical school or a variety of other healthcare fields. Discover what’s next. In Bethel’s Master of Science in Medical ...